Indivior PLC Ordinary Shares (INDV) Stock Analysis

Indivior PLC Ordinary Shares (INDV) is a publicly traded company in the HEALTHCARE sector. It trades at $33.71, carries a market capitalization of $4.12B, a price-to-earnings ratio of 17.89. This page summarizes the public market data, fundamentals, and frequently asked questions for INDV, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Indivior PLC Ordinary Shares currently has a Bullish sentiment score of 0.33.

About Indivior PLC Ordinary Shares

Indivior PLC is a leading global biopharmaceutical company headquartered in North Chesterfield, Virginia, specializing in the development and commercialization of innovative treatments for opioid dependence and related disorders, particularly through its proprietary buprenorphine-based therapies. The company is dedicated to improving patient outcomes by addressing the complex challenges of opioid use disorder and is committed to advancing research and development in this critical area of publ...

GNG Research Analysis

GNG Research scores Indivior PLC Ordinary Shares (INDV) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for INDV.

Frequently Asked Questions

Does INDV pay dividends?

Indivior PLC Ordinary Shares (INDV) does not currently pay a regular dividend.

What is INDV's P/E ratio?

Indivior PLC Ordinary Shares has a price-to-earnings (P/E) ratio of 17.89.

What is INDV's market cap?

Indivior PLC Ordinary Shares (INDV) has a market capitalization of $4.12B with a current stock price of $33.71.